You can narrow down the results using the filters
Improve usability of the Electronic Therapeutic Guidelines
This project aims to improve the usability of the Electronic Therapeutic Guidelines including developing a smartphone app.
Pilot AMS program in veterinary practice
Develop and pilot an antimicrobial stewardship program appropriate for use in companion animal veterinary practices.
Community for Open Access Antimicrobial Drug Discovery (CO-ADD)
CO-ADD screens compounds being used for academic research for antimicrobial activity. This is done for free.
Service Enhancement for Quality Use of Antibiotics in Long Term Care (SEQUAL)
SEQUAL aims to help residential aged care facilities implement a program of antimicrobial stewardship.
National Antimicrobial Prescribing Survey
The National Antimicrobial Prescribing Survey (NAPS) is a standardised auditing tool designed to help health care facilities assess the quantity and quality of local antimicrobial prescribing.
National Centre for Antimicrobial Stewardship
The National Centre for Antimicrobial Stewardship (NCAS) is a health services research program that promotes the rational use of antimicrobial drugs throughout Australia.
The Guidance Group helps hospitals and other clinical facilities to improve their prescribing.
WARRA: Wollongong Antimicrobial Resistance Research Alliance
The Wollongong Antimicrobial Resistance Research Alliance (WARRA) is an initiative of the University of Wollongong, NSW. It aims to generate evidence on antibiotic use and drivers of antimicrobial resistance, to inform future interventions targeting the Illawarra Shoalhaven region.
WARRA: the evolving threat and impact of antimicrobial resistance to the Illawarra Shoalhaven population
The Wollongong Antimicrobial Resistance Research Alliance (WARRA) are conducting a longitudinal study across the Illawarra Shoalhaven region to look at the impact of antimicrobial resistance.
WARRA: the evolving threat and impact of antimicrobial resistance to the Illawarra Shoalhaven population – a service utilisation perspective
This Wollongong Antimicrobial Resistance Research Alliance (WARRA) project aims to examine the relationship between antimicrobial resistance and patient health care service utilisation rates and clinical outcomes across the Illawarra Shoalhaven region.
WARRA: the treatment and impact of antimicrobial resistance across the Illawarra Shoalhaven population
The Wollongong Antimicrobial Resistance Research Alliance (WARRA) aim to identify trends in antimicrobial resistance across the Illawarra Shoalhaven region.
WARRA: antibiotic use and misuse - the development of a community measure
This Wollongong Antimicrobial Resistance Research Alliance (WARRA) project is looking at predicting the use and misuse of antibiotics by developing a questionnaire.
WARRA: a pharmacy engagement initiative for tackling antimicrobial resistance
The Wollongong Antimicrobial Resistance Research Alliance (WARRA) have developed a series of workshops to help tackle antimicrobial resistance.
Investigation of alternative regulatory and reimbursement models for antimicrobial agents
This PhD research project is aimed at investigating alternative regulatory and funding models for antimicrobial drugs.
Antimicrobial Resistance: Science, Communication and Public Engagements (AMR-scapes) is an Australian research project examining how the public engages with advice about the rational and reduced use of antibiotics.
Monash BDI-WMU Alliance in Clinical and Experimental Biomedicine
This collaborative research project is analysing the increase in antimicrobial resistance (AMR) in hospitals in Wenzhou, China.
Discovery and development of bacteriophage for phage therapy
This collaborative research project is isolating clinically effective ‘cocktails’ of bacteriophages that kill bacteria resistant to antimicrobials.
New drugs for bad bugs: dual-functional therapies to treat resistant bacteria
This project is developing new drugs for bacteria resistant to antimicrobials. By augmenting the host’s immune response and removing bacterial evasion mechanisms, it is hoped to overcome bacterial infections.
Overcoming natural constraints to develop new vancomycin-type antibiotics
This project is exploring the properties of new vancomycin derivatives that will address growing bacterial resistance to these compounds.
Discovery and development of new-generation polymyxins against Gram-negative 'superbugs'
This project aims to employ novel approaches to discover new-generation polymyxin antibiotics targeting the deadly Gram-negative ‘superbugs’. Novel lead molecules have been licensed to Qpex Biopharma (US) for IND-enabling evaluations with a Phase-I study aimed at 2020.
How to treat untreatable gonorrhoea
This project uses knowledge recently gained about how gonorrhoea bacteria cause disease to develop new treatments that better control infections.
Antimicrobial prescribing guidelines for pigs
Expert veterinarians have published guidelines (for Australian pig veterinarians) on prescribing antimicrobials for use in pigs. The guidelines have been developed specifically for Australian conditions and reference the most contemporary knowledge available on AMR.
Micro and nano-engineered surfaces for the prevention of microbial adhesion and biofouling
This research project will develop new technologies that will overcome the limitation of micro and nanotechnologies to small areas and flat surfaces.
Whole genome sequencing of Escherichia coli in healthy commercial pigs
This project involves using whole genome sequencing of E. coli and other microbes frequently found in pigs. This will help track the spread of antimicrobial resistance (AMR) genes.
Whole genome sequencing of avian pathogenic Escherichia coli in commercial Australian poultry
This project uses whole genome sequencing of avian pathogenic E. coli (APEC) to demonstrate that Australian APEC carry few antimicrobial resistance (AMR) genes in comparison with overseas APEC.